Wave Life Sciences Ltd. CEO Paul Bolno's 2019 pay falls 39% to $3.6M

Wave Life Sciences Ltd. reports 2019 executive compensation

By ExecPay News

Published: June 26, 2020

Wave Life Sciences Ltd. reported fiscal year 2019 executive compensation information on June 26, 2020.
In 2019, five executives at Wave Life Sciences Ltd. received on average a compensation package of $1.7M, a 36% decrease compared to previous year.
Average pay of disclosed executives at Wave Life Sciences Ltd.
Paul B. Bolno, Chief Executive Officer, received $3.6M in total, which decreased by 39% compared to 2018. 75.39% of Bolno's compensation, or $2.7M, was in stock awards. Bolno also received $282.3K in non-equity incentive plan, $579K in salary, as well as $20.3K in other compensation.
Mark Baldry, Former Chief Commercial Officer, received a compensation package of $1.6M. 48.86% of the compensation package, or $759.7K, was in stock awards.
Michael Panzara, Chief Medical Officer, earned $1.3M in 2019, a 43% decrease compared to previous year.
Chandra Vargeese, Chief Technology Officer, received $1.2M in 2019, which decreases by 43% compared to 2018.
Keith C. Regnante, Chief Financial Officer, earned $1.1M in 2019, a 36% decrease compared to previous year.

Related executives

Paul Bolno

Wave Life Sciences Ltd.

Chief Executive Officer

Keith Regnante

Wave Life Sciences Ltd.

Chief Financial Officer

Mark Baldry

Wave Life Sciences Ltd.

Former Chief Commercial Officer

Michael Panzara

Wave Life Sciences Ltd.

Chief Medical Officer

Chandra Vargeese

Wave Life Sciences Ltd.

Chief Technology Officer

You may also like

Source: SEC filing on June 26, 2020.